col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


210 Ergebisse       Seite 1

 [1] 
Frontiers Media SA: Frontiers in Molecular Biosciences
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Mrz―28 Electrophysiological properties and structural prediction of the SARS-CoV-2 viroprotein E Salvatore Antonio Maria Cubisino, Stefan Milenkovic, Stefano Conti-Nibali, Nicolò Musso, Paolo Bonacci, Vito De Pinto, et al. (+2)
2 [GO] 2024―Mrz―27 Modeling of noncovalent inhibitors of the papain-like protease (PLpro) from SARS-CoV-2 considering the protein flexibility by using molecular dynamics and cross-docking Jorge Luis Valdés-Albuernes, Erbio Díaz-Pico, Sergio Alfaro, Julio Caballero
3 [GO] 2024―Mrz―07 Integrating virtual screening, pharmacoinformatics profiling, and molecular dynamics: identification of promising inhibitors targeting 3CLpro of SARS-CoV-2 Abeer Mohammad, Ahmed Zheoat, Amjad Oraibi, Ajay Manaithiya, Khalid S. Almaary, Hiba Allah Nafidi, et al. (+3)
4 [GO] 2024―Feb―05 Virus sequencing performance during the SARS-CoV-2 pandemic: a retrospective analysis of data from multiple rounds of external quality assessment in Austria Jeremy V. Camp, Elisabeth Puchhammer-Stöckl, Stephan W. Aberle, Christoph Buchta
5 [GO] 2024―Jan―18 Investigation of protein-protein interactions and hotspot region on the NSP7-NSP8 binding site in NSP12 of SARS-CoV-2 José Xavier Lima Neto, Katyanna Sales Bezerra, Emmanuel Duarte Barbosa, Roniel Lima Araujo, Douglas Soares Galvão, Marcelo Leite Lyra, et al. (+6)
6 [GO] 2024―Jan―11 The analysis of low-dose glucocorticoid maintenance therapy in patients with primary nephrotic syndrome suffering from COVID-19 Yong-Qi Li, Min Wu, Yu-Jia Wang, Yu-Xia Zhang, Jing Lu, Yi-Nan Zhao, et al. (+4)
7 [GO] 2024―Jan―05 Design of protein-binding peptides with controlled binding affinity: the case of SARS-CoV-2 receptor binding domain and angiotensin-converting enzyme 2 derived peptides Giacomo Parisi, Roberta Piacentini, Alessio Incocciati, Alessandra Bonamore, Alberto Macone, Jakob Rupert, et al. (+7)
8 [GO] 2023―Nov―29 Oligomer formation of SARS-CoV-2 ORF8 through 73YIDI76 motifs regulates immune response and non-infusion antiviral interactions Mohammad Assadizadeh, Maryam Azimzadeh Irani
9 [GO] 2023―Nov―15 A comparative NMR-based metabolomics study of lung parenchyma of severe COVID-19 patients Joaquín I. Hurtado, Andrés López-Radcenco, José Luis Izquierdo-García, Fernando Rodríguez, Guillermo Moyna, Gonzalo Greif, Nicolás Nin
10 [GO] 2023―Nov―02 Structural understanding of SARS-CoV-2 virus entry to host cells Kim Le, Shrute Kannappan, Truc Kim, Jung Heon Lee, Hye-Ra Lee, Kyeong Kyu Kim
11 [GO] 2023―Okt―31 Corrigendum: VIDIIA Hunter: a low-cost, smartphone connected, artificial intelligence-assisted COVID-19 rapid diagnostic platform approved for medical use in the UK Aurore C. Poirier, Ruben D. Riaño Moreno, Leona Takaindisa, Jessie Carpenter, Jai W. Mehat, Abi Haddon, et al. (+20)
12 [GO] 2023―Okt―10 Unveiling the potential pleiotropic effects of metformin in treating COVID-19: a comprehensive review Pavlo Petakh, Iryna Kamyshna, Aleksandr Kamyshnyi
13 [GO] 2023―Okt―09 Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 on metabolic unhealthy obese patients Tengda Huang, Nan Jiang, Yujia Song, Hongyuan Pan, Ao Du, Bingxuan Yu, et al. (+4)
14 [GO] 2023―Okt―06 Cryo-electron microscopy in the fight against COVID-19-mechanism of virus entry Satish Bodakuntla, Christopher Cyrus Kuhn, Christian Biertümpfel, Naoko Mizuno
15 [GO] 2023―Okt―04 Clinical analysis of prolonged viral clearance time in patients with lymphoma combined with novel coronavirus infection Ying Li, Chao Wu, Liming Fei, Qin Xu, Xianru Shao, Bangjie Chen, Gengyun Sun
16 [GO] 2023―Sep―29 VIDIIA Hunter diagnostic platform: a low-cost, smartphone connected, artificial intelligence-assisted COVID-19 rapid diagnostics approved for medical use in the UK Aurore C. Poirier, Ruben D. Riaño Moreno, Leona Takaindisa, Jessie Carpenter, Jai W. Mehat, Abi Haddon, et al. (+20)
17 [GO] 2023―Sep―11 SARS-CoV-2 infection as a potential risk factor for the development of cancer Natalia Ogarek, Paulina Oboza, Magdalena Olszanecka-Glinianowicz, Piotr Kocelak
18 [GO] 2023―Sep―01 Combining docking, molecular dynamics simulations, AD-MET pharmacokinetics properties, and MMGBSA calculations to create specialized protocols for running effective virtual screening campaigns on the autoimmune disorder and SARS-CoV-2 main protease Emmanuel Israel Edache, Adamu Uzairu, Paul Andrew Mamza, Gideon Adamu Shallangwa, Fatma Hilal Yagin, Nagwan Abdel Samee, Noha F. Mahmoud
19 [GO] 2023―Aug―17 Editorial: The upcoming complications of COVID-19 on recovered patients: molecular mechanisms and therapeutic opportunities, volume II Seyed Hassan Seradj, William C. Cho, Zohreh Amoozgar, Rana Jahanban-Esfahlan
20 [GO] 2023―Aug―02 Editorial: Impact of SARS-CoV-2 on Antibiotic Resistance: Evolution of Treatment and Control Strategies Sanket Kaushik, Vijay Kumar Srivastava, Biswajit Mishra
21 [GO] 2023―Jun―27 Differences in the organization of interface residues tunes the stability of the SARS-CoV-2 spike-ACE2 complex Mattia Miotto, Lorenzo Di Rienzo, Greta Grassmann, Fausta Desantis, Gianluca Cidonio, Giorgio Gosti, et al. (+3)
22 [GO] 2023―Jun―24 Computational study of the binding orientation and affinity of noncovalent inhibitors of the papain-like protease (PLpro) from SARS-CoV-1 considering the protein flexibility by using molecular dynamics and cross-docking Luis Castillo-Campos, José Luis Velázquez-Libera, Julio Caballero
23 [GO] 2023―Jun―19 Bioinformatic and systems biology approach revealing the shared genes and molecular mechanisms between COVID-19 and non-alcoholic hepatitis Huishuang Lu, Jiaxiu Ma, Yalan Li, Jin Zhang, Yaxin An, Wei Du, Xuefei Cai
24 [GO] 2023―Jun―14 COVID-19 and brain-heart-lung microbial fingerprints in Italian cadavers Gulnaz T. Javan, Sheree J. Finley, Matteo Moretti, Silvia D. Visonà, Melissa P. Mezzari, Robert L. Green
25 [GO] 2023―Jun―14 A CRISPR-based approach using dead Cas9-sgRNA to detect SARS-CoV-2 Mustapha Aouida, Maryam Saifaldeen, Dana E. Al-Ansari, Sara Taleb, Ali Ait Hssain, Dindial Ramotar
26 [GO] 2023―Jun―13 Glycosylation of H4 influenza strains with pandemic potential and susceptibilities to lung surfactant SP-D Lisa M. Parsons, Olga Zoueva, Gabrielle Grubbs, Ewan Plant, Ewa Jankowska, Yijia Xie, et al. (+5)
27 [GO] 2023―Jun―01 PI3K/Akt/Nrf2 mediated cellular signaling and virus-host interactions: latest updates on the potential therapeutic management of SARS-CoV-2 infection V. S. Lekshmi, Kumari Asha, Melvin Sanicas, Abhila Asi, U. M. Arya, Binod Kumar
28 [GO] 2023―Apr―26 Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets Grace Kenny, Liam Townsend, Stefano Savinelli, Patrick W. G. Mallon
29 [GO] 2023―Mrz―16 G4-binding drugs, chlorpromazine and prochlorperazine, repurposed against COVID-19 infection in hamsters Shuvra Shekhar Roy, Shalu Sharma, Zaigham Abbas Rizvi, Dipanjali Sinha, Divya Gupta, Mercy Rophina, et al. (+11)
30 [GO] 2023―Mrz―16 Evolution of Indian Influenza A (H1N1) Hemagglutinin Strains: A Comparative Analysis of the Pandemic Californian HA Strain Shilpa Sri Pushan, Mahesh Samantaray, Muthukumaran Rajagopalan, Amutha Ramaswamy
31 [GO] 2023―Mrz―13 Super-infection by multiple microorganisms in COVID-19 patients Andrea C. Gomez, Tamin Ortiz, Angélica Valenzuela, Rocío Egoávil-Espejo, Rosario Huerto-Huanuco, Joseph A. Pinto, et al. (+2)
32 [GO] 2023―Mrz―09 Editorial: Antiviral drug discovery against pathogens of pandemic concern: Advancements in target site identification and structure-based drug development Krishna M. Padmanabha Das
33 [GO] 2023―Mrz―07 Identification of novel inhibitors for SARS-CoV-2 as therapeutic options using machine learning-based virtual screening, molecular docking and MD simulation Abdus Samad, Amar Ajmal, Arif Mahmood, Beenish Khurshid, Ping Li, Syed Mansoor Jan, et al. (+6)
34 [GO] 2023―Feb―15 Metabolomics as a powerful tool for diagnostic, pronostic and drug intervention analysis in COVID-19 Chiara Bruzzone, Ricardo Conde, Nieves Embade, José M. Mato, Oscar Millet
35 [GO] 2023―Feb―03 Specialized pro-resolving lipid mediators regulate inflammatory macrophages: A paradigm shift from antibiotics to immunotherapy for mitigating COVID-19 pandemic Vikram Kumar, Nusrath Yasmeen, Anis Ahmad Chaudhary, Abdullah S. Alawam, Mohammed Al-Zharani, Nosiba Suliman Basher, et al. (+5)
36 [GO] 2023―Jan―11 Plasma enzymatic activity, proteomics and peptidomics in COVID-19-induced sepsis: A novel approach for the analysis of hemostasis Fernando Dos Santos, Joyce B. Li, Nathalia Juocys, Rafi Mazor, Laura Beretta, Nicole G. Coufal, et al. (+6)
37 [GO] 2022―Dez―16 Identification and mechanistic basis of non-ACE2 blocking neutralizing antibodies from COVID-19 patients with deep RNA sequencing and molecular dynamics simulations Alger M. Fredericks, Kyle W. East, Yuanjun Shi, Jinchan Liu, Federica Maschietto, Alfred Ayala, et al. (+10)
38 [GO] 2022―Okt―25 Translocation pause of remdesivir-containing primer/template RNA duplex within SARS-CoV-2’s RNA polymerase complexes Yuanjun Shi, Jimin Wang, Victor S. Batista
39 [GO] 2022―Okt―21 Reduced platelet mitochondrial respiration and oxidative phosphorylation in patients with post COVID-19 syndrome are regenerated after spa rehabilitation and targeted ubiquinol therapy Zuzana Sumbalová, Jarmila Kucharská, Zuzana Rausová, Patrik Palacka, Eleonóra Kovalčíková, Timea Takácsová, et al. (+4)
40 [GO] 2022―Okt―21 Corrigendum: ACE2 in the gut: The center of the 2019-nCoV infected pathology Yuexin Guo, Boya Wang, Han Gao, Lei Gao, Rongxuan Hua, Jing-Dong Xu
41 [GO] 2022―Okt―19 Corrigendum: Decreased interfacial dynamics caused by the N501Y mutation in the SARS-CoV-2 S1 spike:ACE2 complex Wesam S. Ahmed, Angelin M. Philip, Kabir H. Biswas
42 [GO] 2022―Okt―10 Corrigendum: Targeting the N-terminus domain of the coronavirus nucleocapsid protein induces abnormal oligomerization via allosteric modulation Jia-Ning Hsu, Jyun-Siao Chen, Shan-Meng Lin, Jhen-Yi Hong, Yi-Jheng Chen, U-Ser Jeng, et al. (+2)
43 [GO] 2022―Okt―10 Refinement of SARS-CoV-2 envelope protein structure in a native-like environment by molecular dynamics simulations Rui Yang, Sijin Wu, Shen Wang, Grace Rubino, Jonathan D. Nickels, Xiaolin Cheng
44 [GO] 2022―Sep―28 Improvement of native structure-based peptides as efficient inhibitors of protein-protein interactions of SARS-CoV-2 spike protein and human ACE2 Norbert Odolczyk, Joanna Klim, Małgorzata Podsiadła-Białoskórska, Maria Winiewska-Szajewska, Ewa Szolajska, Urszula Zielenkiewicz, et al. (+2)
45 [GO] 2022―Sep―27 Modeling of the thermal properties of SARS-CoV-2 S-protein Ziyuan Niu, Karin Hasegawa, Yuefan Deng, Ziji Zhang, Miriam Rafailovich, Marcia Simon, Peng Zhang
46 [GO] 2022―Sep―26 Cytoplasmic tail determines the membrane trafficking and localization of SARS-CoV-2 spike protein Qinlin Li, Yihan Liu, Leiliang Zhang
47 [GO] 2022―Sep―14 In-silico investigation of systematic missense mutations of middle east respiratory coronavirus spike protein Raina Rhoades, Adebiyi Sobitan, Vidhyanand Mahase, Brhan Gebremedhin, Qiyi Tang, Danda Rawat, et al. (+2)
48 [GO] 2022―Aug―16 Assessing the suitability of long non-coding RNAs as therapeutic targets and biomarkers in SARS-CoV-2 infection Yichen Zhong, Caroline L. Ashley, Megan Steain, Sandro Fernandes Ataide
49 [GO] 2022―Aug―15 Interactions between heparin and SARS-CoV-2 spike glycoprotein RBD from omicron and other variants Adrianne L. Gelbach, Fuming Zhang, Seok-Joon Kwon, John T. Bates, Andrew P. Farmer, Jonathan S. Dordick, et al. (+2)
50 [GO] 2022―Aug―11 Host cell stress response as a predictor of COVID-19 infectivity and disease progression Celine Caillet, Melissa Louise Stofberg, Victor Muleya, Addmore Shonhai, Tawanda Zininga
51 [GO] 2022―Jul―22 Decreased Interfacial Dynamics Caused by the N501Y Mutation in the SARS-CoV-2 S1 Spike:ACE2 Complex Wesam S. Ahmed, Angelin M. Philip, Kabir H. Biswas
52 [GO] 2022―Jul―19 Identification of COVID-19-Specific Immune Markers Using a Machine Learning Method Hao Li, Feiming Huang, Huiping Liao, Zhandong Li, Kaiyan Feng, Tao Huang, Yu-Dong Cai
53 [GO] 2022―Jul―12 Structural Requirements and Plasticity of Receptor-Binding Domain in Human Coronavirus Spike Yajuan Li, Peiyi Zheng, Tingting Liu, Cuixiao Shi, Bo Wang, Yuanhong Xu, Tengchuan Jin
54 [GO] 2022―Jun―30 An Altered Metabolism in Leukocytes Showing in vitro igG Memory From SARS-CoV-2-Infected Patients G. Fanelli, F. Gevi, G. Zarletti, M. Tiberi, V. De Molfetta, G. Scapigliati, A. M. Timperio
55 [GO] 2022―Jun―28 Detection of SARS-CoV-2 Genome in Stool and Plasma Samples of Laboratory Confirmed Iranian COVID-19 Patients Mobin Makhmalbaf, Seyed Masoud Hosseini, Hamid Asadzadeh Aghdaei, Mahsa Saeedi Niasar, Shahrzad Shoraka, Abbas Yadegar, et al. (+6)
56 [GO] 2022―Jun―28 Evaluation of Clove Phytochemicals as Potential Antiviral Drug Candidates Targeting SARS-CoV-2 Main Protease: Computational Docking, Molecular Dynamics Simulation, and Pharmacokinetic Profiling Arun Chandra Manivannan, Arunkumar Malaisamy, Murugesh Eswaran, Arun Meyyazhagan, Vijaya Anand Arumugam, Kannan R. R. Rengasamy, et al. (+2)
57 [GO] 2022―Jun―22 Editorial: Interaction of Biomolecules and Bioactive Compounds With the SARS-CoV-2 Proteins: Molecular Simulations for the Fight Against Covid-19 Mattia Falconi, James Leland Olds, Arvind Ramanathan
58 [GO] 2022―Jun―09 Clinical and Gene Features of SARS-CoV-2-Positive Recurrence in Patients Recovered From COVID-19 Yuying Peng, Shaoqi Wang, Ruihuan Chai, Yong Chen, Nan Li, Boning Zeng, et al. (+7)
59 [GO] 2022―Mai―23 Editorial: The Upcoming Complications of COVID-19 on Recovered Patients: Molecular Mechanisms and Therapeutic Opportunities Rana Jahanban-Esfahlan, Seyed Hassan Seradj, Zohreh Amoozgar, William C. Cho
60 [GO] 2022―Mai―23 Biochemical Characterization of SARS-CoV-2 Spike RBD Mutations and Their Impact on ACE2 Receptor Binding Abdullah Hoter, Hassan Y. Naim
61 [GO] 2022―Mai―20 Shape Complementarity Optimization of Antibody-Antigen Interfaces: The Application to SARS-CoV-2 Spike Protein Alfredo De Lauro, Lorenzo Di Rienzo, Mattia Miotto, Pier Paolo Olimpieri, Edoardo Milanetti, Giancarlo Ruocco
62 [GO] 2022―Mai―19 Molecular and Clinical Investigation of COVID-19: From Pathogenesis and Immune Responses to Novel Diagnosis and Treatment Narjes Riahi Kashani, Javid Azadbakht, Hassan Ehteram, Hamed Haddad Kashani, Hassan Rajabi-Moghadam, Ejaz Ahmad, et al. (+2)
63 [GO] 2022―Mai―13 Dysregulated Exosomes Result in Suppression of the Immune Response of Pregnant COVID-19 Convalescent Women Hang Cao, Nor Haslinda Abd Aziz, Janet Raja Xavier, Mohamad Nasir Shafiee, Aida Kalok, Babban Jee, et al. (+2)
64 [GO] 2022―Mai―11 Phase Separation Drives SARS-CoV-2 Replication: A Hypothesis Andrea Vandelli, Giovanni Vocino, Gian Gaetano Tartaglia
65 [GO] 2022―Mai―10 Identifying Methylation Signatures and Rules for COVID-19 With Machine Learning Methods Zhandong Li, Zi Mei, Shijian Ding, Lei Chen, Hao Li, Kaiyan Feng, et al. (+2)
66 [GO] 2022―Mai―10 Potential of Natural Alkaloids From Jadwar (Delphinium denudatum) as Inhibitors Against Main Protease of COVID-19: A Molecular Modeling Approach Anuj Kumar, Mansi Sharma, Christopher D. Richardson, David J. Kelvin
67 [GO] 2022―Apr―29 Comparing the Nucleocapsid Proteins of Human Coronaviruses: Structure, Immunoregulation, Vaccine, and Targeted Drug Bo Zhang, Junjie Tian, Qintao Zhang, Yan Xie, Kejia Wang, Shuyi Qiu, et al. (+2)
68 [GO] 2022―Apr―27 Comparative Analysis of Long Non-Coding RNA Expression and Immune Response in Mild and Severe COVID-19 Yongting Zhang, Fan Shi, Yuchong Wang, Yuting Meng, Qiong Zhang, Kaihang Wang, et al. (+2)
69 [GO] 2022―Apr―19 Targeting the N-Terminus Domain of the Coronavirus Nucleocapsid Protein Induces Abnormal Oligomerization via Allosteric Modulation Jia-Ning Hsu, Jyun-Siao Chen, Shan-Meng Lin, Jhen-Yi Hong, Yi-Jheng Chen, U-Ser Jeng, et al. (+2)
70 [GO] 2022―Apr―14 Multisystem Inflammatory Syndrome and Autoimmune Diseases Following COVID-19: Molecular Mechanisms and Therapeutic Opportunities Parastoo Hosseini, Mohammad Sadegh Fallahi, Gisou Erabi, Majid Pakdin, Seyed Mahdi Zarezadeh, Arezoo Faridzadeh, et al. (+4)
71 [GO] 2022―Apr―11 Serum NMR Profiling Reveals Differential Alterations in the Lipoproteome Induced by Pfizer-BioNTech Vaccine in COVID-19 Recovered Subjects and Naïve Subjects Veronica Ghini, Laura Maggi, Alessio Mazzoni, Michele Spinicci, Lorenzo Zammarchi, Alessandro Bartoloni, et al. (+2)
72 [GO] 2022―Apr―01 A Rapid, Highly Sensitive and Open-Access SARS-CoV-2 Detection Assay for Laboratory and Home Testing Max J. Kellner, James J. Ross, Jakob Schnabl, Marcus P. S. Dekens, Martin Matl, Robert Heinen, et al. (+14)
73 [GO] 2022―Mrz―31 Corrigendum: Immune Response in Myocardial Injury: In Situ Hybridization and Immunohistochemistry Techniques for SARS-CoV-2 Detection in COVID-19 Autopsies Pek Yoon Chong, Jabed Iqbal, Joe Yeong, Tar Choon Aw, Kian Sing Chan, Paul Chui
74 [GO] 2022―Mrz―29 The Molecular Basis of the Effect of Temperature on the Structure and Function of SARS-CoV-2 Spike Protein Faez Iqbal Khan, Kevin A. Lobb, Dakun Lai
75 [GO] 2022―Mrz―28 Tuftsin: A Natural Molecule Against SARS-CoV-2 Infection Jiahao Huang, Jing Wang, Yan Li, Ziyuan Wang, Ming Chu, Yuedan Wang
76 [GO] 2022―Mrz―28 Antigen-Antibody Complex-Guided Exploration of the Hotspots Conferring the Immune-Escaping Ability of the SARS-CoV-2 RBD Kit-Man Fung, Shu-Jung Lai, Tzu-Lu Lin, Tien-Sheng Tseng
77 [GO] 2022―Mrz―14 Computational Repurposing of Drugs and Natural Products Against SARS-CoV-2 Main Protease (Mpro) as Potential COVID-19 Therapies Sakshi Piplani, Puneet Singh, Nikolai Petrovsky, David A. Winkler
78 [GO] 2022―Mrz―14 Host Cell Glycocalyx Remodeling Reveals SARS-CoV-2 Spike Protein Glycomic Binding Sites Ying Sheng, Anita Vinjamuri, Michael Russelle S. Alvarez, Yixuan Xie, Marisa McGrath, Siyu Chen, et al. (+3)
79 [GO] 2022―Mrz―11 Exploring New Characteristics: Using Deep Learning and 3D Reconstruction to Compare the Original COVID-19 and Its Delta Variant Based on Chest CT Na Bai, Ruikai Lin, Zhiwei Wang, Shengyan Cai, Jianliang Huang, Zhongrui Su, et al. (+9)
80 [GO] 2022―Mrz―08 Identifying SARS-CoV-2 Lineage Mutation Hallmarks and Correlating Them With Clinical Outcomes in Egypt: A Pilot Study Sara H. A. Agwa, Hesham Elghazaly, Mahmoud Shawky El Meteini, Yahia A. Yahia, Radwa Khaled, Aya M. Abd Elsamee, et al. (+6)
81 [GO] 2022―Feb―24 Significance of Cardiac Troponins as an Identification Tool in COVID-19 Patients Using Biosensors: An Update Yousef Rasmi, Osama F. Mosa, Shahriar Alipour, Nadia Heidari, Farzaneh Javanmard, Ali Golchin, Shiva Gholizadeh-Ghaleh Aziz
82 [GO] 2022―Feb―23 Changes of Small Non-coding RNAs by Severe Acute Respiratory Syndrome Coronavirus 2 Infection Wenzhe Wu, Eun-Jin Choi, Binbin Wang, Ke Zhang, Awadalkareem Adam, Gengming Huang, et al. (+9)
83 [GO] 2022―Feb―18 The Physical Basis for pH Sensitivity in Biomolecular Structure and Function, With Application to the Spike Protein of SARS-CoV-2 Jim Warwicker
84 [GO] 2022―Feb―14 SARS-CoV-2 Spike Protein Unlikely to Bind to Integrins via the Arg-Gly-Asp (RGD) Motif of the Receptor Binding Domain: Evidence From Structural Analysis and Microscale Accelerated Molecular Dynamics Houcemeddine Othman, Haifa Ben Messaoud, Oussema Khamessi, Hazem Ben-Mabrouk, Kais Ghedira, Avani Bharuthram, et al. (+4)
85 [GO] 2022―Feb―08 In Silico Infection Analysis (iSFA) Identified Coronavirus Infection and Potential Transmission Risk in Mammals Yanyan Zou, Xiaojian Cao, Bing Yang, Lulu Deng, Yangyang Xu, Shuang Dong, et al. (+3)
86 [GO] 2022―Feb―04 Phytochemicals of Euphorbia hirta L. and Their Inhibitory Potential Against SARS-CoV-2 Main Protease Ruel Cayona, Evelyn Creencia
87 [GO] 2022―Feb―03 Three Month Follow-Up of Patients With COVID-19 Pneumonia Complicated by Pulmonary Embolism Cecilia Calabrese, Anna Annunziata, Martina Flora, Domenica Francesca Mariniello, Valentino Allocca, Maria Ilaria Palma, et al. (+4)
88 [GO] 2022―Feb―03 Susceptibility to Metabolic Diseases in COVID-19: To be or Not to be an Issue Maryam Kaviani, Somayeh Keshtkar, Saeede Soleimanian, Fatemeh Sabet Sarvestani, Negar Azarpira, Sara Pakbaz
89 [GO] 2022―Jan―28 Cancer Occurrence as the Upcoming Complications of COVID-19 Ilnaz Rahimmanesh, Laleh Shariati, Nasim Dana, Yasaman Esmaeili, Golnaz Vaseghi, Shaghayegh Haghjooy Javanmard
90 [GO] 2022―Jan―27 Molecular Docking and Dynamics Studies to Explore Effective Inhibitory Peptides Against the Spike Receptor Binding Domain of SARS-CoV-2 Suvro Biswas, Shafi Mahmud, Mohasana Akter Mita, Shamima Afrose, Md. Robiul Hasan, Mst. Sharmin Sultana Shimu, et al. (+5)
91 [GO] 2022―Jan―24 A Computer-Aided Approach for the Discovery of D-Peptides as Inhibitors of SARS-CoV-2 Main Protease Jorge E. Hernández González, Raphael J. Eberle, Dieter Willbold, Mônika A. Coronado
92 [GO] 2022―Jan―18 The Tissue Distribution of SARS-CoV-2 in Transgenic Mice With Inducible Ubiquitous Expression of hACE2 Alexander A. Dolskiy, Andrey S. Gudymo, Oleg S. Taranov, Irina V. Grishchenko, Ekaterina M. Shitik, Dmitry Yu Prokopov, et al. (+17)
93 [GO] 2022―Jan―12 Molecular Mechanism of SARS-CoVs Orf6 Targeting the Rae1-Nup98 Complex to Compete With mRNA Nuclear Export Tinghan Li, Yibo Wen, Hangtian Guo, Tingting Yang, Haitao Yang, Xiaoyun Ji
94 [GO] 2022―Jan―11 CRISPR Technology in Gene-Editing-Based Detection and Treatment of SARS-CoV-2 Behrouz Shademan, Alireza Nourazarian, Saba Hajazimian, Alireza Isazadeh, Cigir Biray Avci, Mahin Ahangar Oskouee
95 [GO] 2022―Jan―03 The Oral Complications of COVID-19 Xinxuan Zhou, Jiajia Dong, Qiang Guo, Mingyun Li, Yan Li, Lei Cheng, Biao Ren
96 [GO] 2021―Dez―20 GSTP1 and GSTM3 Variant Alleles Affect Susceptibility and Severity of COVID-19 Vesna Coric, Ivana Milosevic, Tatjana Djukic, Zoran Bukumiric, Ana Savic-Radojevic, Marija Matic, et al. (+8)
97 [GO] 2021―Dez―15 NCOA4-Mediated Ferritinophagy: A Vicious Culprit in COVID-19 Pathogenesis? Fengju Jia, Hongxia Liu, Shan Kang
98 [GO] 2021―Dez―13 Computational Insights Into the Effects of the R190K and N121Q Mutations on the SARS-CoV-2 Spike Complex With Biliverdin Zhiyuan Qu, Kaihang Li, Xiaoju Geng, Bo Huang, Jian Gao
99 [GO] 2021―Dez―09 Computational Saturation Mutagenesis of SARS-CoV-1 Spike Glycoprotein: Stability, Binding Affinity, and Comparison With SARS-CoV-2 Adebiyi Sobitan, Vidhyanand Mahase, Raina Rhoades, Dejaun Williams, Dongxiao Liu, Yixin Xie, et al. (+3)
100 [GO] 2021―Dez―02 Metabolic and Lipidomic Markers Differentiate COVID-19 From Non-Hospitalized and Other Intensive Care Patients Franziska Schmelter, Bandik Föh, Alvaro Mallagaray, Johann Rahmöller, Marc Ehlers, Selina Lehrian, et al. (+14)
101 [GO] 2021―Dez―01 Pleural Mesothelial Cells Modulate the Inflammatory/Profibrotic Response During SARS-CoV-2 Infection Giulia Matusali, Flavia Trionfetti, Veronica Bordoni, Roberta Nardacci, Laura Falasca, Daniele Colombo, et al. (+9)
102 [GO] 2021―Nov―08 Prediction of Non-canonical Routes for SARS-CoV-2 Infection in Human Placenta Cells Flávia Bessi Constantino, Sarah Santiloni Cury, Celia Regina Nogueira, Robson Francisco Carvalho, Luis Antonio Justulin
103 [GO] 2021―Okt―26 Immune Response in Myocardial Injury: In Situ Hybridization and Immunohistochemistry Techniques for SARS-CoV-2 Detection in COVID-19 Autopsies Pek Yoon Chong, Jabed Iqbal, Joe Yeong, Tar Choon Aw, Kian Sing Chan, Paul Chui
104 [GO] 2021―Okt―25 SARS-CoV-2 UK, South African and Brazilian Variants in Karachi- Pakistan Adnan Khan, Muhammad Hanif, Akhtar Ahmed, Sarosh Syed, Saqib Ghazali, Rafiq Khanani
105 [GO] 2021―Okt―07 Respiratory Outcomes in Patients Following COVID-19-Related Hospitalization: A Meta-Analysis Tao Guo, Fangfang Jiang, Yufei Liu, Yunpeng Zhao, Yiran Li, Yihua Wang
106 [GO] 2021―Sep―21 ACE2 in the Gut: The Center of the 2019-nCoV Infected Pathology Yuexin Guo, Boya Wang, Han Gao, Lei Gao, Rongxuan Hua, Jing-Dong Xu
107 [GO] 2021―Sep―17 The Molecular Basis of Gender Variations in Mortality Rates Associated With the Novel Coronavirus (COVID-19) Outbreak Ibrahim Y. Hachim, Mahmood Y. Hachim, Iman Mamdouh Talaat, Vanessa M. López-Ozuna, Narjes Saheb Sharif-Askari, Saba Al Heialy, et al. (+2)
108 [GO] 2021―Sep―07 Microbial Metabolites: The Emerging Hotspot of Antiviral Compounds as Potential Candidates to Avert Viral Pandemic Alike COVID-19 Topu Raihan, Muhammad Fazle Rabbee, Puja Roy, Swapnila Choudhury, Kwang-Hyun Baek, Abul Kalam Azad
109 [GO] 2021―Sep―03 Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza Yalda Rahbar Saadat, Seyed Mahdi Hosseiniyan Khatibi, Sepideh Zununi Vahed, Mohammadreza Ardalan
110 [GO] 2021―Aug―20 Molecular Dynamics Simulations Reveal the Interaction Fingerprint of Remdesivir Triphosphate Pivotal in Allosteric Regulation of SARS-CoV-2 RdRp Mitul Srivastava, Lovika Mittal, Anita Kumari, Shailendra Asthana
111 [GO] 2021―Aug―12 DNA Aptamers Block the Receptor Binding Domain at the Spike Protein of SARS-CoV-2 Fabrizio Cleri, Marc F. Lensink, Ralf Blossey
112 [GO] 2021―Aug―05 Corrigendum: Synthesis and Cytotoxic Activity of Novel Indole Derivatives and Their in silico Screening on Spike Glycoprotein of SARS-CoV-2 Perumal Gobinath, Ponnusamy Packialakshmi, Kaliappillai Vijayakumar, Magda H. Abdellattif, Mohd Shahbaaz, Akbar Idhayadhulla, Radhakrishnan Surendrakumar
113 [GO] 2021―Jul―28 SARS-CoV-2 Spike Protein Extrapolation for COVID Diagnosis and Vaccine Development Yashpal S. Malik, Prashant Kumar, Mohd Ikram Ansari, Maged G. Hemida, Mohamed E. El Zowalaty, Ahmed S. Abdel-Moneim, et al. (+11)
114 [GO] 2021―Jul―27 Non-RBM Mutations Impaired SARS-CoV-2 Spike Protein Regulated to the ACE2 Receptor Based on Molecular Dynamic Simulation Yaoqiang Du, Hao Wang, Linjie Chen, Quan Fang, Biqin Zhang, Luxi Jiang, et al. (+6)
115 [GO] 2021―Jul―23 Evaluation and Comparison of Serological Methods for COVID-19 Diagnosis Fanwu Gong, Hua-xing Wei, Qiangsheng Li, Liu Liu, Bofeng Li
116 [GO] 2021―Jul―22 Management of Coronavirus Disease 2019 Patients With Lung Cancer: Experience From a Thoracic Oncology Center David Barros Coelho, Vanessa Santos, David Araújo, Hélder Novais Bastos, Adriana Magalhães, Venceslau Hespanhol, et al. (+3)
117 [GO] 2021―Jul―21 The Potential Role of Extracellular Vesicles in COVID-19 Treatment: Opportunity and Challenge Yan-yan Yan, Wen-min Zhou, Yu-qing Wang, Qiao-ru Guo, Fu-xi Zhao, Zhuang-yan Zhu, et al. (+6)
118 [GO] 2021―Jul―20 A Validated Mathematical Model of the Cytokine Release Syndrome in Severe COVID-19 Ruy Freitas Reis, Alexandre Bittencourt Pigozzo, Carla Rezende Barbosa Bonin, Barbara de Melo Quintela, Lara Turetta Pompei, Ana Carolina Vieira, et al. (+4)
119 [GO] 2021―Jul―12 Correlation Analysis Between Serum Uric Acid, Prealbumin Level, Lactate Dehydrogenase, and Severity of COVID-19 Zhenmu Jin, Mo Zheng, Jichan Shi, Xinchun Ye, Fang Cheng, Que-Lu Chen, et al. (+2)
120 [GO] 2021―Jul―12 Current Perspectives in the Discovery of Newer Medications Against the Outbreak of COVID-19 M. Ramesh, Krishnan Anand, Mohd Shahbaaz, Magda H. Abdellattif
121 [GO] 2021―Jul―12 Mathematical Model of SARS-Cov-2 Propagation Versus ACE2 Fits COVID-19 Lethality Across Age and Sex and Predicts That of SARS Ugo Bastolla
122 [GO] 2021―Jul―09 Discovery of Small-Molecule Inhibitors of SARS-CoV-2 Proteins Using a Computational and Experimental Pipeline Edmond Y. Lau, Oscar A. Negrete, W. F. Drew Bennett, Brian J. Bennion, Monica Borucki, Feliza Bourguet, et al. (+25)
123 [GO] 2021―Jul―05 In silico Screening of Natural Phytocompounds Towards Identification of Potential Lead Compounds to Treat COVID-19 Muthumanickam Sankar, Balajee Ramachandran, Boomi Pandi, Nachiappan Mutharasappan, Vidhyavathi Ramasamy, Poorani Gurumallesh Prabu, et al. (+9)
124 [GO] 2021―Jul―02 Indian Ethnomedicinal Phytochemicals as Promising Inhibitors of RNA-Binding Domain of SARS-CoV-2 Nucleocapsid Phosphoprotein: An In Silico Study Sankar Muthumanickam, Arumugam Kamaladevi, Pandi Boomi, Shanmugaraj Gowrishankar, Shunmugiah Karutha Pandian
125 [GO] 2021―Jul―01 Management and Thinking on the Treatment of Cancer Patients During the COVID-19 Shuangyue Pan, Jiahong Jiang, Zheling Chen, Liu Yang
126 [GO] 2021―Jun―30 The Role of Indoor Plants in air Purification and Human Health in the Context of COVID-19 Pandemic: A Proposal for a Novel Line of Inquiry Rania El-Tanbouly, Ziad Hassan, Sarah El-Messeiry
127 [GO] 2021―Jun―21 Ramping Up Antimicrobial Peptides Against Severe Acute Respiratory Syndrome Coronavirus-2 Santosh K. Ghosh, Aaron Weinberg
128 [GO] 2021―Jun―11 Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer Jingwen Yue, Weihua Jin, Hua Yang, John Faulkner, Xuehong Song, Hong Qiu, et al. (+5)
129 [GO] 2021―Jun―09 A Minireview of the Promising Drugs and Vaccines in Pipeline for the Treatment of COVID-19 and Current Update on Clinical Trials Jeyanthi Venkadapathi, Venkat Kumar Govindarajan, Saravanan Sekaran, Santhi Venkatapathy
130 [GO] 2021―Jun―09 In-Silico Evidence for a Two Receptor Based Strategy of SARS-CoV-2 Edoardo Milanetti, Mattia Miotto, Lorenzo Di Rienzo, Madhu Nagaraj, Michele Monti, Thaddeus W. Golbek, et al. (+5)
131 [GO] 2021―Jun―04 Sex-Related Overactivation of NLRP3 Inflammasome Increases Lethality of the Male COVID-19 Patients Hongliang Zhang, Yujie Tang, Jinhui Tao
132 [GO] 2021―Mai―31 Potent Molecular Feature-based Neutralizing Monoclonal Antibodies as Promising Therapeutics Against SARS-CoV-2 Infection Arnaud John Kombe Kombe, Ayesha Zahid, Ahmed Mohammed, Ronghua Shi, Tengchuan Jin
133 [GO] 2021―Mai―26 Initial PCR Testing Negative, but Chest CT Suggesting for Viral Pneumonia Urges for Repeated Testing for COVID-19 Diagnosis Lingwei Wang, Danting Zhan, Xiaodi Liu, Kai Yang, Shipin Wu, Heng Zhang, et al. (+6)
134 [GO] 2021―Mai―26 Appraisals of the Bangladeshi Medicinal Plant Calotropis gigantea Used by Folk Medicine Practitioners in the Management of COVID-19: A Biochemical and Computational Approach Mycal Dutta, Mohammad Nezam, Subrata Chowdhury, Ahmed Rakib, Arkajyoti Paul, Saad Ahmed Sami, et al. (+8)
135 [GO] 2021―Mai―24 The Therapeutic Potential of Galectin-3 in the Treatment of Intrahepatic Cholangiocarcinoma Patients and Those Compromised With COVID-19 Hao Li, Jianmin Li, Wei Xiao, Yujing Zhang, Yuan Lv, Xing Yu, Jiao Zheng
136 [GO] 2021―Mai―24 Scrutinizing Coronaviruses Using Publicly Available Bioinformatic Tools: The Viral Structural Proteins as a Case Study Sonia Beeckmans, Edilbert Van Driessche
137 [GO] 2021―Mai―17 An Integrated Computational and Experimental Approach to Identifying Inhibitors for SARS-CoV-2 3CL Protease Tianhua Zhai, Fangyuan Zhang, Shozeb Haider, Daniel Kraut, Zuyi Huang
138 [GO] 2021―Mai―13 Current Strategies of Antiviral Drug Discovery for COVID-19 Miao Mei, Xu Tan
139 [GO] 2021―Mai―11 Synthesis and Cytotoxic Activity of Novel Indole Derivatives and Their in silico Screening on Spike Glycoprotein of SARS-CoV-2 Perumal Gobinath, Ponnusamy Packialakshmi, Daoud Ali, Saud Alarifi, Amal Alotaibi, Akbar Idhayadhulla, Radhakrishnan Surendrakumar
140 [GO] 2021―Mai―10 Prospective Role of Peptide-Based Antiviral Therapy Against the Main Protease of SARS-CoV-2 Shafi Mahmud, Gobindo Kumar Paul, Suvro Biswas, Shamima Afrose, Mohasana Akter Mita, Md. Robiul Hasan, et al. (+9)
141 [GO] 2021―Mai―10 Large-Scale Recombinant Production of the SARS-CoV-2 Proteome for High-Throughput and Structural Biology Applications Nadide Altincekic, Sophie Marianne Korn, Nusrat Shahin Qureshi, Marie Dujardin, Martí Ninot-Pedrosa, Rupert Abele, et al. (+123)
142 [GO] 2021―Mai―05 A Strategy Based on Loop Analysis to Develop Peptide Epitopes: Application to SARS-CoV-2 Spike Protein Maria Luisa Di Vona, Gian Maria Rossolini, Marco Sette
143 [GO] 2021―Apr―22 Antibodies and Vaccines Target RBD of SARS-CoV-2 Long Min, Qiu Sun
144 [GO] 2021―Apr―20 Impact of Ribosome Activity on SARS-CoV-2 LNP - Based mRNA Vaccines Evangelos Tsiambas, Aristeidis Chrysovergis, Vasileios Papanikolaou, Nicholas Mastronikolis, Vasileios Ragos, Anna Batistatou, et al. (+4)
145 [GO] 2021―Apr―15 Developmental Landscape of Potential Vaccine Candidates Based on Viral Vector for Prophylaxis of COVID-19 Rajashri Bezbaruah, Pobitra Borah, Bibhuti Bhushan Kakoti, Nizar A. Al-Shar’I, Balakumar Chandrasekaran, Da’san M. M. Jaradat, et al. (+2)
146 [GO] 2021―Apr―15 Administration Timing and Efficacy of Tocilizumab in Patients With COVID-19 and Elevated IL-6 Pan Li, Zhengmao Lu, Qiang Li, Zhenmeng Wang, Yan Guo, Chen Cai, et al. (+12)
147 [GO] 2021―Apr―13 High-Flow Nasal Cannula for COVID-19 Patients: A Multicenter Retrospective Study in China Jun Duan, Jia Zeng, Puyu Deng, Zhong Ni, Rongli Lu, Wenxi Xia, et al. (+5)
148 [GO] 2021―Apr―13 Glycans of SARS-CoV-2 Spike Protein in Virus Infection and Antibody Production Xiaohui Zhao, Huan Chen, Hongliang Wang
149 [GO] 2021―Apr―12 Gastrointestinal Microenvironment and the Gut-Lung Axis in the Immune Responses of Severe COVID-19 Yun Yang, Weishan Huang, Yubo Fan, Guo-Qiang Chen
150 [GO] 2021―Apr―12 Inhibition of SARS-CoV-2 3CL Mpro by Natural and Synthetic Inhibitors: Potential Implication for Vaccine Production Against COVID-19 Anwar Ullah, Kifayat Ullah
151 [GO] 2021―Apr―12 The Deadly Duo of COVID-19 and Cancer! Vivek R. Bora, Bhoomika M. Patel
152 [GO] 2021―Apr―09 Structure-Based Virtual Screening to Identify Novel Potential Compound as an Alternative to Remdesivir to Overcome the RdRp Protein Mutations in SARS-CoV-2 Thirumal Kumar D, Nishaat Shaikh, Udhaya Kumar S, George Priya Doss C, Hatem Zayed
153 [GO] 2021―Mrz―31 A Multifunctional Peptide From Bacillus Fermented Soybean for Effective Inhibition of SARS-CoV-2 S1 Receptor Binding Domain and Modulation of Toll Like Receptor 4: A Molecular Docking Study Srichandan Padhi, Samurailatpam Sanjukta, Rounak Chourasia, Rajendra K. Labala, Sudhir P. Singh, Amit K. Rai
154 [GO] 2021―Mrz―30 Chest CT Images for COVID-19: Radiologists and Computer-Based Detection Qingli Dou, Jiangping Liu, Wenwu Zhang, Yanan Gu, Wan-Ting Hsu, Kuan-Ching Ho, et al. (+3)
155 [GO] 2021―Mrz―25 Perspectives on RNA Vaccine Candidates for COVID-19 Pobitra Borah, Pran Kishore Deb, Nizar A. Al-Shar’i, Lina A. Dahabiyeh, Katharigatta N. Venugopala, Vinayak Singh, et al. (+5)
156 [GO] 2021―Mrz―18 Circulating Nucleosomes as Potential Markers to Monitor COVID-19 Disease Progression Etienne Cavalier, Julien Guiot, Katharina Lechner, Alexander Dutsch, Mark Eccleston, Marielle Herzog, et al. (+4)
157 [GO] 2021―Mrz―16 An Overview of Spike Surface Glycoprotein in Severe Acute Respiratory Syndrome-Coronavirus Muthu Kumaradoss Kathiravan, Srimathi Radhakrishnan, Vigneshwaran Namasivayam, Senthilkumar Palaniappan
158 [GO] 2021―Mrz―08 Emerging Therapeutic Approaches to Combat COVID-19: Present Status and Future Perspectives Karthik Vivekanandhan, Poornima Shanmugam, Hamed Barabadi, Vigneshwaran Arumugam, Dharun Daniel Raj Daniel Paul Raj, Manikandan Sivasubramanian, et al. (+6)
159 [GO] 2021―Feb―26 Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection Biswa Mohan Sahoo, B. V. V. Ravi Kumar, J. Sruti, Manoj Kumar Mahapatra, Bimal K. Banik, Preetismita Borah
160 [GO] 2021―Feb―22 Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection Elettra Barberis, Virginia V. Vanella, Marco Falasca, Valeria Caneapero, Giuseppe Cappellano, Davide Raineri, et al. (+14)
161 [GO] 2021―Feb―20 Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted Pobitra Borah, Pran Kishore Deb, Balakumar Chandrasekaran, Manoj Goyal, Monika Bansal, Snawar Hussain, et al. (+5)
162 [GO] 2021―Feb―15 Molecular Mechanisms Behind Anti SARS-CoV-2 Action of Lactoferrin Mattia Miotto, Lorenzo Di Rienzo, Leonardo Bò, Alberto Boffi, Giancarlo Ruocco, Edoardo Milanetti
163 [GO] 2021―Feb―08 New Insights Into Potential Benefits of Bioactive Compounds of Bee Products on COVID-19: A Review and Assessment of Recent Research Ehab Kotb Elmahallawy, Yasser Mohamed, Walied Abdo, Fatma A. El-Gohary, Shaimaa Ahmed Awad Ali, Tokuma Yanai
164 [GO] 2021―Feb―04 Therapeutic Strategies in the Management of COVID-19 Rajashri R. Naik, Ashok K. Shakya
165 [GO] 2021―Jan―27 SARS-CoV-2 Proteins Exploit Host’s Genetic and Epigenetic Mediators for the Annexation of Key Host Signaling Pathways Md. Abdullah-Al-Kamran Khan, Abul Bashar Mir Md. Khademul Islam
166 [GO] 2021―Jan―25 Elucidating the Interactions Between Heparin/Heparan Sulfate and SARS-CoV-2-Related Proteins-An Important Strategy for Developing Novel Therapeutics for the COVID-19 Pandemic Mingjia Yu, Tianji Zhang, Wei Zhang, Qianyun Sun, Hongmei Li, Jin-ping Li
167 [GO] 2021―Jan―25 A Revisit to the Research Updates of Drugs, Vaccines, and Bioinformatics Approaches in Combating COVID-19 Pandemic Tofael Ahmed Sumon, Md. Ashraf Hussain, Md. Tawheed Hasan, Mahmudul Hasan, Won Je Jang, Eleus Hussain Bhuiya, et al. (+5)
168 [GO] 2021―Jan―19 In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19 Divya M. Teli, Mamta B. Shah, Mahesh T. Chhabria
169 [GO] 2021―Jan―14 In vitro Dissolution Profile at Different Biological pH Conditions of Hydroxychloroquine Sulfate Tablets Is Available for the Treatment of COVID-19 Thirupathi Dongala, Naresh Kumar Katari, Santhosh Kumar Ettaboina, Anand Krishnan, Murtaza M. Tambuwala, Kamal Dua
170 [GO] 2021―Jan―13 Characteristics of COVID-19 Patients Based on the Results of Nucleic Acid and Specific Antibodies and the Clinical Relevance of Antibody Levels Hao Chen, Rundong Qin, Zhifeng Huang, Li He, Wenting Luo, Peiyan Zheng, et al. (+3)
171 [GO] 2021―Jan―13 SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells Shiv Bharadwaj, Mahendra Singh, Nikhil Kirtipal, Sang Gu Kang
172 [GO] 2021―Jan―07 Exploring the Potential of Carbon Dots to Combat COVID-19 Sabna Kotta, Hibah Mubarak Aldawsari, Shaimaa M. Badr-Eldin, Nabil A. Alhakamy, Shadab Md, Anroop B. Nair, Pran Kishore Deb
173 [GO] 2021―Jan―07 The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic Ludwig Aigner, Frank Pietrantonio, Diana Marisa Bessa de Sousa, Johanna Michael, Daniela Schuster, Herbert Anton Reitsamer, et al. (+2)
174 [GO] 2021―Jan―07 Molecular Docking and Molecular Dynamics Aided Virtual Search of OliveNet™ Directory for Secoiridoids to Combat SARS-CoV-2 Infection and Associated Hyperinflammatory Responses Neelaveni Thangavel, Mohammad Al Bratty, Hassan Ahmad Al Hazmi, Asim Najmi, Reem Othman Ali Alaqi
175 [GO] 2020―Dez―23 Molecular Docking Studies on the Anti-viral Effects of Compounds From Kabasura Kudineer on SARS-CoV-2 3CLpro Savariar Vincent, Selvaraj Arokiyaraj, Muthupandian Saravanan, Manoj Dhanraj
176 [GO] 2020―Dez―23 Visual Detection of SARS-CoV-2 RNA by Conventional PCR-Induced Generation of DNAzyme Sensor Anbalagan Anantharaj, Soon Jyoti Das, Patil Sharanabasava, Rakesh Lodha, Sushil K. Kabra, Tarun Kumar Sharma, Guruprasad R. Medigeshi
177 [GO] 2020―Dez―18 Deletion of BST2 Cytoplasmic and Transmembrane N-Terminal Domains Results in SARS-CoV, SARS-CoV-2, and Influenza Virus Production Suppression in a Vero Cell Line Alexander A. Dolskiy, Sergei A. Bodnev, Anastasia A. Nazarenko, Anastasia M. Smirnova, Olga G. Pyankova, Anna K. Matveeva, et al. (+7)
178 [GO] 2020―Dez―18 Identification of Potential Inhibitors of 3CL Protease of SARS-CoV-2 From ZINC Database by Molecular Docking-Based Virtual Screening Ashraf Ahmed Ali Abdusalam, Vikneswaran Murugaiyah
179 [GO] 2020―Dez―18 Surveying the Side-Chain Network Approach to Protein Structure and Dynamics: The SARS-CoV-2 Spike Protein as an Illustrative Case Anushka Halder, Arinnia Anto, Varsha Subramanyan, Moitrayee Bhattacharyya, Smitha Vishveshwara, Saraswathi Vishveshwara
180 [GO] 2020―Dez―17 Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be Giuseppina Mariano, Rebecca J. Farthing, Shamar L. M. Lale-Farjat, Julien R. C. Bergeron
181 [GO] 2020―Dez―14 Potential Mechanisms for Traditional Chinese Medicine in Treating Airway Mucus Hypersecretion Associated With Coronavirus Disease 2019 Yuanfeng Zhang, Zheyi Wang, Yue Zhang, Hongxuan Tong, Yiling Zhang, Tao Lu
182 [GO] 2020―Dez―11 A Potential Peptide From Soy Cheese Produced Using Lactobacillus delbrueckii WS4 for Effective Inhibition of SARS-CoV-2 Main Protease and S1 Glycoprotein Rounak Chourasia, Srichandan Padhi, Loreni Chiring Phukon, Md Minhajul Abedin, Sudhir P. Singh, Amit Kumar Rai
183 [GO] 2020―Dez―11 Fetal Metabolomic Alterations Following Porcine Reproductive and Respiratory Syndrome Virus Infection Carolina M. Malgarin, Daniel J. MacPhee, John C. S. Harding
184 [GO] 2020―Dez―09 Spike Proteins of SARS-CoV and SARS-CoV-2 Utilize Different Mechanisms to Bind With Human ACE2 Yixin Xie, Chitra B. Karki, Dan Du, Haotian Li, Jun Wang, Adebiyi Sobitan, et al. (+3)
185 [GO] 2020―Dez―04 Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19 Wen Cui, Kailin Yang, Haitao Yang
186 [GO] 2020―Nov―24 Computational Investigation of Structural Dynamics of SARS-CoV-2 Methyltransferase-Stimulatory Factor Heterodimer nsp16/nsp10 Bound to the Cofactor SAM Md Fulbabu Sk, Nisha Amarnath Jonniya, Rajarshi Roy, Sayan Poddar, Parimal Kar
187 [GO] 2020―Nov―20 Renal Carcinoma Is Associated With Increased Risk of Coronavirus Infections Satyendra C. Tripathi, Vishwajit Deshmukh, Chad J. Creighton, Ashlesh Patil
188 [GO] 2020―Nov―17 Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives Sabna Kotta, Hibah Mubarak Aldawsari, Shaimaa M. Badr-Eldin, Nabil Abdulhafiz Alhakamy, Shadab Md, Anroop B. Nair, Pran Kishore Deb
189 [GO] 2020―Okt―23 Systematic Analysis of Coronavirus Disease 2019 (COVID-19) Receptor ACE2 in Malignant Tumors: Pan-Cancer Analysis Jukun Song, Jing Han, Feng Liu, Xianlin Chen, Shenqi Qian, Yadong Wang, et al. (+4)
190 [GO] 2020―Okt―16 Identifying Pathways and Networks Associated With the SARS-CoV-2 Cell Receptor ACE2 Based on Gene Expression Profiles in Normal and SARS-CoV-2-Infected Human Tissues Qiushi Feng, Lin Li, Xiaosheng Wang
191 [GO] 2020―Okt―16 Investigation of the Effect of Temperature on the Structure of SARS-CoV-2 Spike Protein by Molecular Dynamics Simulations Soumya Lipsa Rath, Kishant Kumar
192 [GO] 2020―Okt―15 Determine the Potential Epitope Based Peptide Vaccine Against Novel SARS-CoV-2 Targeting Structural Proteins Using Immunoinformatics Approaches Muhammad Waqas, Ali Haider, Muhammad Sufyan, Sami Siraj, Sheikh Arslan Sehgal
193 [GO] 2020―Okt―14 COVID-19: Targeting Proteases in Viral Invasion and Host Immune Response Sanchit Seth, Jyotsna Batra, Srilakshmi Srinivasan
194 [GO] 2020―Okt―08 ssRNA Virus and Host Lipid Rearrangements: Is There a Role for Lipid Droplets in SARS-CoV-2 Infection? Francesca Pagliari, Maria Grazia Marafioti, Geraldine Genard, Patrizio Candeloro, Giuseppe Viglietto, Joao Seco, Luca Tirinato
195 [GO] 2020―Sep―30 Discovery of Potential Flavonoid Inhibitors Against COVID-19 3CL Proteinase Based on Virtual Screening Strategy Zhongren Xu, Lixiang Yang, Xinghao Zhang, Qiling Zhang, Zhibin Yang, Yuanhao Liu, et al. (+2)
196 [GO] 2020―Sep―30 ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives Federica Saponaro, Grazia Rutigliano, Simona Sestito, Lavinia Bandini, Barbara Storti, Ranieri Bizzarri, Riccardo Zucchi
197 [GO] 2020―Sep―23 Computational Study of the Ion and Water Permeation and Transport Mechanisms of the SARS-CoV-2 Pentameric E Protein Channel Yipeng Cao, Rui Yang, Wei Wang, Imshik Lee, Ruiping Zhang, Wenwen Zhang, et al. (+3)
198 [GO] 2020―Sep―18 SARS-CoV-2 Virion Stabilization by Zn Binding Silvia Morante, Giovanni La Penna, Giancarlo Rossi, Francesco Stellato
199 [GO] 2020―Sep―10 Can CRISPR/Cas Technology Be a Felicitous Stratagem Against the COVID-19 Fiasco? Prospects and Hitches Rocktotpal Konwarh
200 [GO] 2020―Sep―01 Prepare for the Future: Dissecting the Spike to Seek Broadly Neutralizing Antibodies and Universal Vaccine for Pandemic Coronaviruses Luca Vangelista, Massimiliano Secchi
201 [GO] 2020―Aug―25 Drug Weaponry to Fight Against SARS-CoV-2 Elena Cabezón, Ignacio Arechaga
202 [GO] 2020―Aug―21 SR/RS Motifs as Critical Determinants of Coronavirus Life Cycle Eleni Nikolakaki, Thomas Giannakouros
203 [GO] 2020―Aug―21 Bioactive Virus-Mimicking Nanovesicles From Dendrimersomes: A Novel Approach to Understanding SARS-CoV-2 Host-Interactions to Better Design Therapeutics Bilal Javed
204 [GO] 2020―Aug―11 Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19 Swapan K. Chatterjee, Snigdha Saha, Maria Nilda M. Munoz
205 [GO] 2020―Aug―11 COVID-19: Looking Into the Overlooked Fernanda Cristina Petersen, Ulf Reidar Dahle, Belinda Nicolau, Climent Casals-Pascual
206 [GO] 2020―Aug―07 Combination Therapy Using Inhalable GapmeR and Recombinant ACE2 for COVID-19 Navin Kumar Verma, Mobashar Hussain Urf Turabe Fazil, Shane P. Duggan, Dermot Kelleher
207 [GO] 2020―Aug―04 Insights Into Dynamics of Inhibitor and Ubiquitin-Like Protein Binding in SARS-CoV-2 Papain-Like Protease Yuliana K. Bosken, Timothy Cholko, Yuan-Chao Lou, Kuen-Phon Wu, Chia-en A. Chang
208 [GO] 2020―Aug―03 A Multi-Targeting Approach to Fight SARS-CoV-2 Attachment Luciano Pirone, Annarita Del Gatto, Sonia Di Gaetano, Michele Saviano, Domenica Capasso, Laura Zaccaro, Emilia Pedone
209 [GO] 2020―Jul―03 Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19 Bicheng Zhang, Xiaoyang Zhou, Chengliang Zhu, Yuxiao Song, Fan Feng, Yanru Qiu, et al. (+5)
210 [GO] 2020―Jun―05 Does Early Childhood Vaccination Protect Against COVID-19? Karzan R. Sidiq, Dana Khdr Sabir, Shakhawan M. Ali, Rimantas Kodzius
 [1] 

210 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.019 sec